Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 18,600
-490 (-2.57%)
Last updated: Jun 4, 2026, 2:26 PM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 133.04 billion as of June 3, 2026. Its market cap has increased by 20.82% in one year.
Market Cap
133.04B
Enterprise Value
-92.96B
Revenue
64.38B
Ranking
n/a
PE Ratio
110.46
Stock Price
18,600.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 133.04B, an increase of 654.81%. That is a compound annual growth rate of 7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 133.04B | -12.43% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 170.47B |
| Hana Pharm | 166.35B |
| Jeil Pharmaceutical Co.,Ltd | 165.68B |
| AptaBio Therapeutics | 156.48B |
| Daihan Pharmaceutical | 154.94B |
| Samil Pharmaceutical Co.,Ltd | 154.13B |
| Ilyang Pharmaceutical Co.,Ltd | 152.90B |
| Dongwha Pharm.Co.,Ltd | 152.73B |